Efficacy of Combination Therapy with Lenvatinib and Radioactive Iodine in Thyroid Cancer Preclinical Model

Patients with differentiated thyroid cancer (DTC) usually have good prognosis, while those with advanced disease have poor clinical outcomes. This study aimed to investigate the antitumor effects of combination therapy with lenvatinib and (131)I (CTLI) using three different types of DTC cell lines w...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Kensuke, Iwai, Hiroshi, Utsunomiya, Keita, Kono, Yumiko, Watabe, Tadashi, Kobayashi, Yoshiki, Bui, Dan Van, Sawada, Shunsuke, Yun, Yasutaka, Mitani, Akitoshi, Fukui, Kenta, Sakai, Haruka, Chu, Hanh Hong, Linh, Nguyen Manh, Tanigawa, Noboru, Kanda, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456011/
https://www.ncbi.nlm.nih.gov/pubmed/36077268
http://dx.doi.org/10.3390/ijms23179872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456011/
https://www.ncbi.nlm.nih.gov/pubmed/36077268
http://dx.doi.org/10.3390/ijms23179872

Ejemplares similares